Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3683727014 | Product containing atropine and hyoscyamine and scopolamine in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683728016 | Atropine and hyoscyamine and scopolamine in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683729012 | Product containing atropine and hyoscyamine and scopolamine in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3708650014 | Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3708651013 | Atropine- and hyoscyamine- and scopolamine-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3708652018 | Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Has active ingredient | Scopolamine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Is a | Product containing atropine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Has active ingredient | Atropine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Is a | Product containing hyoscyamine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Has active ingredient | Hyoscyamine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Is a | Product containing atropine and hyoscyamine and scopolamine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Is a | Product containing scopolamine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet | Is a | False | Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Is a | True | Product containing atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR